Back
ACVC Premium Access

SGLT2 inhibition: a new horizon in type-2 diabetes

Session: Risk reduction after acute coronary syndrome
Topic: Miscellaneous
Speaker: Professor D. Grobbee (Utrecht, NL)
Event: Acute Cardiovascular Care 2016

Congress Presentation

About the speaker

Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))
38 presentations
10 followers

3 more presentations in this session

Thrombosis and anti thrombotics – lessons from recent RCTs.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Access
Slides
Video
Thumbnail

Is there still a role for beta blockers in patients with preserved LV function?

Speaker: Professor D. Zahger (Beer Sheva, IL)

Access
Slides
Video
Thumbnail

The role of non invasive imaging for risk assessment.

Speaker: Professor N. Cardim (Lisbon, PT)

Access
Slides
Video
Thumbnail

Access the full session

Risk reduction after acute coronary syndrome

Speakers: Professor D. Grobbee, Professor P. Clemmensen, Professor D. Zahger, Professor N. Cardim
Access
Thumbnail

About the event

Image

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb